The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic impact of high stromal tumor-infiltrating lymphocytes (sTIL) in the absence of pathologic complete response (pCR) to neoadjuvant therapy (NAT) in early stage triple negative breast cancer (TNBC).
 
Nour Abuhadra
No Relationships to Disclose
 
Ryan Sun
No Relationships to Disclose
 
Jennifer Keating Litton
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Medivation/Pfizer; Pfizer
Speakers' Bureau - Clinical Care Options; Med Learning Group; Medpage; Medscape; Physicans' Education Resource; Prime Oncology; UpToDate
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Medivation/Pfizer (Inst); Novartis (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Clinical Care Options; Med Learning Group; Medscape; Physicans' Education Resource
Other Relationship - Medivation/Pfizer
 
Gaiane M Rauch
No Relationships to Disclose
 
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Travel, Accommodations, Expenses - Novartis (I); Pfizer
 
Bora Lim
Consulting or Advisory Role - AstraZeneca; Lilly; Natera; Novartis
Research Funding - Calithera Biosciences; Genentech; Merck; Puma Biotechnology; Takeda
 
Beatriz E Adrada
No Relationships to Disclose
 
Elizabeth A. Mittendorf
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Genomic Health; Merck; Merck; Peregrine Pharmaceuticals; Sellas Life Sciences; TapImmune Inc.
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Galena Biopharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline
 
Jason B White
Employment - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - Two patents pending at AstraZeneca/Medimmune related to antibody-drug conjugate technology.
 
Elizabeth Ravenberg
No Relationships to Disclose
 
Senthil Damodaran
Honoraria - Novartis
Consulting or Advisory Role - Pfizer; Taiho Pharmaceutical; Tempus
Research Funding - EMD Serono (Inst); Guardant Health (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Phillips Gilmore Oncology Communications
 
Rosalind P Candelaria
No Relationships to Disclose
 
Banu Arun
Consulting or Advisory Role - Abbvie; Bright Pink
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Naoto T. Ueno
Honoraria - Amgen; Chugai/Roche; Eisai; Henry Stewart Talks; Kyowa Hakko Kirin; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Immunomedics; Samsung Bioepis
Research Funding - Amgen; Bayer; Bio-Path Holdings; Celgene; Daiichi Sankyo; GlaxoSmithKline; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Puma Biotechnology; Sysmex
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Lumarie Santiago
No Relationships to Disclose
 
Rashmi Krishna Murthy
Honoraria - Daiichi Sankyo; Genentech; Puma Biotechnology; Puma Biotechnology; Seagen
Consulting or Advisory Role - Daiichi Sankyo; Genentech/Roche; Puma Biotechnology; Puma Biotechnology; Seagen
Research Funding - Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Genentech; Puma Biotechnology; Puma Biotechnology; Seagen
 
Nuhad K. Ibrahim
Honoraria - Celgene; Novartis; Roche
Consulting or Advisory Role - Immunomedics
Speakers' Bureau - Celgene; Novartis; Roche
Research Funding - Nektar
Travel, Accommodations, Expenses - Novartis; Roche
 
William Fraser Symmans
Stock and Other Ownership Interests - Delphi Diagnostics; ISIS Pharmaceuticals; Nuvera Biosciences
Consulting or Advisory Role - Almac Diagnostics; Merck
Patents, Royalties, Other Intellectual Property - Intellectual property; Intellectual Property (expired)
Travel, Accommodations, Expenses - Luminex; Merck
 
Stacy L. Moulder
Research Funding - Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)
 
Lei Huo
No Relationships to Disclose